Company Number: 13135561

Analysis Date: 2025-07-20 16:07 UTC

1. Credit Opinion: DECLINE
   Genureka Properties Ltd shows persistent net liabilities and negative shareholders’ funds over the past four years, indicating weak financial stability. The company’s current liabilities exceed current assets by a significant margin, resulting in negative working capital and raising concerns about short-term liquidity and ability to meet debt obligations. There is no evidence of profit generation or improvement in equity, which implies limited capacity to service new or existing credit facilities without additional capital injection.

2. Financial Strength:
   The company’s balance sheet is dominated by fixed assets (£274,510), likely property holdings, but this is heavily leveraged with long-term creditors (£189,495) exceeding net assets. Net liabilities stand at -£2,506 as of 31 March 2024, an improvement from prior years but still negative. Negative shareholders’ funds show accumulated losses or undercapitalization. The company’s micro entity status suggests minimal operational scale, and the lack of equity buffer poses a risk for creditors.

3. Cash Flow Assessment:
   Current assets are minimal (£4,970), primarily cash or receivables, while current liabilities are substantial (£92,491), resulting in a negative net current asset position (-£87,521). This indicates tight liquidity and potential cash flow pressure to cover short-term obligations. The absence of a profit and loss statement limits cash flow analysis, but repeated negative working capital and no growth in current assets suggest cash flow constraints.

4. Monitoring Points:

• Watch for any capital injections or equity strengthening to improve net worth.
• Monitor changes in current liabilities and efforts to reduce short-term debt.
• Track cash flow improvements or operational profitability if P&L data becomes available.
• Attention to directors’ actions on financial restructuring or asset disposals to enhance liquidity.
• Any late filings or deteriorations in financial health should trigger immediate review.